CD14 and ovarian carcinoma: To that end, we isolated the cellular components from the peritoneal ascites fluid of 8 women with ovarian carcinoma and assayed for the expression of IRG1. In parallel, we assayed these samples for CD14+ monocytes by flow cytometry.